These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fused pyrimidines. Synthesis of new derivatives of potential diuretic activity. Eisa HM; el-Ashmawy MB; Tayel MM; el-Magd SA; el-Kashef HA Boll Chim Farm; 1996 Nov; 135(10):585-90. PubMed ID: 9048447 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of analgesic, anti-inflammatory and ulcerogenic activities of some triazolo- and 2-pyrazolyl-pyrido[2,3-d]-pyrimidines. Hafez HN; Abbas HA; El-Gazzar AR Acta Pharm; 2008 Dec; 58(4):359-78. PubMed ID: 19103572 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and conformational analysis of 3-substituted derivatives of 1H, 3H-pyrido[2,3-d]pyrimidin-4-one of expected depressive activity on central nervous system. Part II. Herold F; Kleps J; Chodkowski A; Gutkowska B Acta Pol Pharm; 1999; 56(5):385-97. PubMed ID: 10646329 [TBL] [Abstract][Full Text] [Related]
5. Amino-substituted 1,8-naphthyridines and pyrido[2,3-d]pyrimidines: new compounds with affinity for A1- and A2-adenosine receptors. Müller CE; Grahner B; Heber D Pharmazie; 1994 Dec; 49(12):878-80. PubMed ID: 7838877 [TBL] [Abstract][Full Text] [Related]
6. New efficient route to dissymmetric 2,4-di(het)aryl-pyrido[3,2-d]pyrimidines via regioselective cross-coupling reactions. Tikad A; Routier S; Akssira M; Leger JM; Jarry C; Guillaumet G Org Lett; 2007 Nov; 9(23):4673-6. PubMed ID: 17949094 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological properties of some new 3-(2-N,N-dialkylaminoethyl)-pyrido [2,3-d]-pyrymidin-4-ones. Kowalska T; Kowalski P; Rutkowski K; Woźniak M; Kleinrok Z; Jagiełło-Wójtowicz E; Szurska G; Chodkowska A Acta Pol Pharm; 1994; 51(2):143-8. PubMed ID: 7863787 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of 4-pyrido-6-aryl-2-substituted amino pyrimidines as a new class of antimalarial agents. Agarwal A; Srivastava K; Puri SK; Chauhan PM Bioorg Med Chem; 2005 Nov; 13(22):6226-32. PubMed ID: 16054819 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of new pyrido[4',3':4,5]thieno[2,3-d]-1,2,4-triazolo[3,4-c]pyrimidines and a 5,6-dihydro-1,2,4-triazolo[4",3":1',2']pyrido[4',3':4,5]thieno [2,3-d]-pyrimidine ring system. Ahmed EK; Gohar AM; Ameen MA Pharmazie; 2000 Jan; 55(1):31-4. PubMed ID: 10683868 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antihypertensive activity of novel 1-(4-benzyl-1-phthalazinyl)-pyrazolo[3,4-d]pyrimidines. el-Feky SA; Abd el-Samii ZK Pharmazie; 1996 Aug; 51(8):540-3. PubMed ID: 8794464 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, chemical and pharmacological properties of some 2,4-dioxo-1,2,3,4,5,6,7,8-octahydropyrimido [4,5-d]pyrimidines. Sladowska H; Sieklucka-Dziuba M; Rajtar G; Wydro R; Kleinrok Z Acta Pol Pharm; 1996; 53(1):39-46. PubMed ID: 8960282 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of nucleosides of 5,7-disubstituted pyrido [2,3-d] pyrimidines and their antibacterial activity. Gupta A; Prakash L Boll Chim Farm; 1994 Mar; 133(3):163-6. PubMed ID: 8011277 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of pyridylethenyl derivatives of 3H-pyrido[2,3-d]-pyrimidyn-4-on of expected depressive activity on central nervous system. Part I. Herold F; Gutkowska B; Baranowski A; Kałucka M; Helbin E Acta Pol Pharm; 1994; 51(3):257-62. PubMed ID: 7872018 [TBL] [Abstract][Full Text] [Related]
14. Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidines. Gangjee A; Adair O; Queener SF J Med Chem; 1999 Jul; 42(13):2447-55. PubMed ID: 10395486 [TBL] [Abstract][Full Text] [Related]
15. Convenient synthesis of novel 4-substitutedamino-5-trifluoromethyl-2,7-disubstituted pyrido[2,3-d] pyrimidines and their antibacterial activity. Ravi Kantha S; Venkat Reddy G; Hara Kishore K; Shanthan Rao P; Narsaiaha B; Surya Narayana Murthy U Eur J Med Chem; 2006 Aug; 41(8):1011-6. PubMed ID: 16766088 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological action of some pyrido-[1,3]-diazepine and pyrido-[2, 3-d]-pyrimidine derivatives. Sołoducho J; Mrozikiewicz A; Bobkiewicz-Kozłowska T Pol J Pharmacol Pharm; 1983; 35(2):131-7. PubMed ID: 6622296 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents. El-Gazzar AR; Hafez HN Bioorg Med Chem Lett; 2009 Jul; 19(13):3392-7. PubMed ID: 19481936 [TBL] [Abstract][Full Text] [Related]
18. Tyrosine kinase inhibitors. 12. Synthesis and structure-activity relationships for 6-substituted 4-(phenylamino)pyrimido[5,4-d]pyrimidines designed as inhibitors of the epidermal growth factor receptor. Rewcastle GW; Bridges AJ; Fry DW; Rubin JR; Denny WA J Med Chem; 1997 Jun; 40(12):1820-6. PubMed ID: 9191958 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of new derivatives of 1-alkyl-2-aryl-1H-2,3-dihydroimidazo[1,2-a]pyrimidin-5-one active in CNS. Part 2. Synthesis and results of preliminary pharmacological screening of 7-(substituted)amino-1-alkyl-2-aryl-1H-2,3-dihydroimidazo[1,2-a]pyrimid in-5- ones. Matosiuk D; Tkaczyński T; Stefańczyk J Acta Pol Pharm; 1999; 56(3):215-9. PubMed ID: 10635361 [TBL] [Abstract][Full Text] [Related]
20. [A new synthesis method for pyrido[1,2-a]thieno[3,2-d]pyrimidine]. Briel D Pharmazie; 2003 Nov; 58(11):836-7. PubMed ID: 14664343 [No Abstract] [Full Text] [Related] [Next] [New Search]